Medical News

RSS

Calif. Gov. Schwarzenegger plans health cuts; news outlets report on Medicaid funding issues

California Gov. Arnold Schwarzenegger is planning cuts to health programs and has "warned more would come if the federal government does not increase program reimbursements," ModernHealthcare reports. "His $82.9 billion spending plan for fiscal 2010-11 includes $750 million in cuts to Medi-Cal, the state's Medicaid program. Prison medical care would be cut by $811 million under his plan." Schwarzenegger is seeking $1.8 billion more in Medicaid funds by raising California's match to the national average for the program — 57 percent (Vesely, 1/8).

12 Jan 2010

Lawmakers, public grapple with health care endgame

Many Democrats consider their health overhaul increasingly politically dicey now, but "are betting that the only thing worse than passing a bill many of them don't like is not passing one at all," the San Francisco Chronicle reports.

12 Jan 2010

TriLink BioTechnologies and tebu-bio SA sign distribution agreement

TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, announced it has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp(TM) products. tebu-bio is a European based distributor that supplies over 750,000 reagents and lab services from manufacturers worldwide.

12 Jan 2010

AnaptysBio, Roche sign agreement for development of novel antibody therapeutics

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has signed an agreement with Roche for the development of novel antibody therapeutics.

12 Jan 2010

Molina Healthcare announces preliminary results of fourth-quarter ended December 31, 2009

Molina Healthcare, Inc. announced today that, based on its preliminary unaudited analysis, it expects to report a loss per diluted share for the fourth quarter of 2009 in the range of $0.10 to $0.25, and earnings for the year ended December 31, 2009, in the range of $1.12 to $1.26.

12 Jan 2010

Medical Care Technologies reaches definitive agreement to acquire GUC's technologies

Medical Care Technologies Inc. today announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, ("GUC") a private Hong Kong corporation.

12 Jan 2010

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm’s proprietary Ligand Activated Therapy (LAT) prodrug approach.

12 Jan 2010

Researchers discover new ways for treatment of cancer

Researchers at the Swedish medical university Karolinska Institutet have discovered a new way of blocking the formation of blood vessels and halting the growth of tumours in mice. A substance that exploits this mechanism could be developed into a new treatment for cancer.

12 Jan 2010

New therapeutic treatment may provide a potential alternative to bone grafting operation

A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.

12 Jan 2010

Obama administration supports Cairo conference goals, Clinton says

Secretary of State Hillary Rodham Clinton on Friday "reiterated the Obama administration's support" for universal access to family planning, improving maternal health care and other goals outlined at the 1995 International Conference on Population and Development Action Plan held in Cairo, Egypt, All Headline News reports.

12 Jan 2010

Interim results from Phase I clinical trials utilizing PLX-PAD for treatment of CLI reported

Pluristem Therapeutics Inc. today announced interim results from their Phase I clinical trials utilizing their placenta derived cell therapy product, PLX-PAD, for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).

12 Jan 2010

Study suggests friendship can provide an alternative to eating and help promote active lifestyles

Parents are acutely aware of the influence of friends on their children's behavior -- how they dress, how they wear their hair, whether they drink or smoke.

12 Jan 2010

In weekly address, Obama focuses on immediate benefits of health bill

"President Obama said Saturday that Americans would see immediate benefits from a landmark overhaul of the nation's health insurance system, and he urged Congress to reconcile swiftly differences on the legislation so it could be signed into law in the coming weeks," The New York Times reports.

12 Jan 2010

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.

12 Jan 2010

Obama to meet with labor leaders to push 'Cadillac' tax in health overhaul legislation

"President Barack Obama, facing growing resistance among Democrats over his support for taxing health benefits, will confront U.S. labor leaders and House lawmakers this week on the issue."

11 Jan 2010

AASLD supports IOM study that recommends ways to reduce viral hepatitis B and C

The American Association for the Study of Liver Disease (AASLD) today reacted favorably to the release by they Institute of Medicine (IOM) of the report of "Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C." This landmark study evaluated the burden from viral hepatitis and current preventive and management practices and recommended ways to reduce new cases of hepatitis B and C and morbidity and mortality from chronic disease.

11 Jan 2010

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex and Galderma Laboratories, L.P. have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (“AK”).

11 Jan 2010

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis (hay fever) by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

11 Jan 2010

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.

11 Jan 2010

MedAssets and TPC sign multi-year agreement

MedAssets, Inc. today announced that the Texas Purchasing Coalition (TPC) has signed a multi-year agreement to utilize and benefit from MedAssets’ strategic supply chain solutions, including group purchasing (GPO) services, physician preference item (PPI) consulting services and spend management analytics. The

11 Jan 2010

Medical News

Calif. Gov. Schwarzenegger plans health cuts; news outlets report on Medicaid funding issues

Lawmakers, public grapple with health care endgame

TriLink BioTechnologies and tebu-bio SA sign distribution agreement

AnaptysBio, Roche sign agreement for development of novel antibody therapeutics

Molina Healthcare announces preliminary results of fourth-quarter ended December 31, 2009

Medical Care Technologies reaches definitive agreement to acquire GUC's technologies

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

Researchers discover new ways for treatment of cancer

New therapeutic treatment may provide a potential alternative to bone grafting operation

Obama administration supports Cairo conference goals, Clinton says

Interim results from Phase I clinical trials utilizing PLX-PAD for treatment of CLI reported

Study suggests friendship can provide an alternative to eating and help promote active lifestyles

In weekly address, Obama focuses on immediate benefits of health bill

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

Obama to meet with labor leaders to push 'Cadillac' tax in health overhaul legislation

AASLD supports IOM study that recommends ways to reduce viral hepatitis B and C

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

MedAssets and TPC sign multi-year agreement

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News